TP53 and neoplasm: Certain tumor types have an exceptionally high preponderance of mutations in TP53: for example, mutations in TP53 occur in 96% of all serous ovarian tumors [2], and nearly all serous and ~25% of high-grade endometrioid endometrial cancers have mutations in TP53 [3].